Product Information
POTASSIUM CL ER 20 MEQ TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.1408 per EA under NDC 00904729361. Its NADAC has been published 154 times since Oct 25, 2023.
FDA first approved this application on May 8, 2020.
Strength
1500 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904729361
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212861FDA Approved
5/8/2020
On Market Since
5/1/2023
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 20 MEQ TABLET has been published 154 times since Oct 25, 2023, and over the history we have for it it has declined 5.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1408 per EA |
|---|---|
| All-time high | $0.1715 (Dec 13, 2023) |
| All-time low | $0.1196 (Jul 17, 2024) |
| 52-week high | $0.1467 |
| 52-week low | $0.1333 |
| Median price | $0.1418 |
| Average price | $0.1425 |
| Largest weekly change | -21.7% (Apr 17, 2024) |
| Weeks tracked | 154 |
| Tracking since | Oct 25, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 20 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 20 MEQ TABLET, manufactured by Major Pharmaceuticals, is $0.1408 per EA (NDC 00904729361), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 20 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has declined 5.3%. It has been tracked across 154 weekly CMS publications since Oct 25, 2023.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 20 MEQ TABLET?
Since Oct 25, 2023, the NADAC for POTASSIUM CL ER 20 MEQ TABLET has ranged from a low of $0.1196 (Jul 17, 2024) to a high of $0.1715 (Dec 13, 2023), with a median of $0.1418 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 20 MEQ TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 20 MEQ TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CL ER 20 MEQ TABLET?
POTASSIUM CL ER 20 MEQ TABLET (NDC 00904729361) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.